Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis. EClinicalMedicine, 2025
Are there any side effects when using GLP-1 medications for arthritis
Journal of Pediatric Surgery
Moreover, a new post-ovulatory population of secretory cells ( PAEP , SCGB1D2 , CCL20 , DEFB1 , CXCL8 ) emerges (Fig
"Because we are treating that whole patient, we meet the standard of care for reimbursement and we are unique in that aspect of being an insurance-reimbursed American Board of Obesity Medicine-style program." Obesity management requires oversight for patients to successfully keep the weight off, Richardson noted, and Form Health focuses on long-term treatment plans rather than just prescribing medications